Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Earnings momentum for Bemis Company, Inc. (BMS - Analyst Report) is flying higher following its healthy third quarter earnings beat and upward guidance revision. Shares of this flexible packaging products maker hit the new 52-week high on October 25, the same day as its earnings report. This Zacks #1 Rank (Strong Buy) stands to gain from the savings of its facility consolidation program, higher sales from certain high-barrier food packaging products and an improving sales mix.
Bemis Tops in Q3
On October 25, Bemis reported adjusted third-quarter earnings per share of 60 cents, which trounced the Zacks Consensus Estimate by more than 11%. This marked the companys fourth straight beat.
Net sales slipped 5% year over year to roughly $1.3 billion. Contributions from acquisitions were more than masked by lower unit volume in the flexible packaging business segment and unfavorable currency translation.
The company raised its earnings forecast for 2012 to between $2.10 and $2.15 per share from the earlier view of $2.00 to $2.10. This optimism reflects the expected savings from facility consolidation.
Earnings Estimates Moving Higher
For 2012, all eight estimates have been revised higher in the last 30 days, boosting the Zacks Consensus Estimate by roughly 4% to $2.12 a share. This indicates an estimated annualized growth of about 6.7%.
Eight estimates out of ten have moved higher for 2013 over the same period. The Zacks Consensus Estimate advanced approximately 3% to $2.30 per share, representing a projected year-over-year growth of 8.5%.
Reasonable Valuation
Bemis is currently trading at a premium on a P/E basis. It is currently trading at a forward P/E of 15.79x, a roughly 13.4% premium to the peer group average of 13.92x. Moreover, its trailing twelve months P/E of 16.11x is higher than the peer group average of 14.41x. The price-to-book of 2.14x is, however, lower than the peer group average of 3.72x. The valuation looks reasonable considering the companys earnings growth prospects.
Sound Technicals
Technical indicators show that Bemis has been trading above its 50-day and 200-day moving averages since September 2012. Following a bullish crossover in October 2012, the 50-day moving average is higher than the 200-day moving average of late, reflecting the bullish trend.
On the performance front, Bemis has outperformed the S&P 500 over the past year, delivering a return of roughly 21% versus 15% for the benchmark.
Founded in 1858, Bemis Company Inc. makes flexible packaging products and pressure sensitive materials for a host of industries, including food, chemical, pharmaceutical, personal care, electronics, automotive and construction. Its offerings include multi-layer flexible polymer film structures, blown and cast stretch film products, carton sealing tapes, adhesive coated paper and film substrates. Bemis, which has a market cap of around $3.5 billion, employs roughly 20,000 people in 80 manufacturing facilities across the U.S., Canada, Mexico, South America, Europe and Australasia.
Want More of Our Best Recommendations?
Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.
Learn More>>
Get the full Analyst Report on BMS - FREE